Cleared Traditional

K223259 - coactiv+™ Antimicrobial Wound Gel (FDA 510(k) Clearance)

May 2023
Decision
212d
Days
-
Risk

K223259 is an FDA 510(k) clearance for the coactiv+™ Antimicrobial Wound Gel. This device is classified as a Dressing, Wound, Drug.

Submitted by Kane Biotech, Inc. (Winnipeg, CA). The FDA issued a Cleared decision on May 24, 2023, 212 days after receiving the submission on October 24, 2022.

This device falls under the General & Plastic Surgery FDA review panel.

Submission Details

510(k) Number K223259 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 2022
Decision Date May 24, 2023
Days to Decision 212 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FRO - Dressing, Wound, Drug
Device Class -

Similar Devices - FRO Dressing, Wound, Drug

All 21
MiraChlor Antimicrobial Wound Solution
K252023 · Letus Corporation · Mar 2026
Promogran Prisma™ Collagen Matrix with ORC and Silver
K251999 · Solventum Germany GmbH · Mar 2026
LUOFUCON® Antimicrobial Wound Gel
K252028 · Huizhou Foryou Medical Co., Ltd. · Mar 2026
Redermax Antibacterial Wound Matrix
K251582 · Beijing Kreate Medical Co., Ltd. · Feb 2026
New Day Skin Spray
K252568 · Silk Holdings, Inc. · Jan 2026
SBC1 Cream
K250890 · Sioxmed, LLC · Jan 2026